Research News

Is There a Link Between Youth Suicide and COVID-19? UK Suicidologist Explains

Feb 24, 2021, 2:18 PM

“It is too early to tell if 2020 youth suicide death rates are up — this data takes more than a year to compile. But we’re hearing suicide deaths seem to be down, even if attempts and help-seeking are way up,” Julie Cerel said.

'Behind the Blue': Rebecca Dutch Discusses Current Efforts in Fighting COVID-19

Feb 22, 2021, 8:50 AM

On this episode of "Behind the Blue," Dutch talks about the new vaccines being used to combat the coronavirus, the genetic variations of the virus that are appearing in different parts of the world, her outlook for when we may emerge from the pandemic, and more.

Screen%20Shot%202021-02-08%20at%2011.24.09%20AM_0.png

Recruitment Begins for Two-Dose, Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Feb 10, 2021, 10:29 AM

The Phase 3 ENSEMBLE 2 study is a randomized, double-blind, placebo-controlled clinical trial in up to 30,000 adults 18 years old and older. The trial will include people both with and without comorbidities associated with an increased risk for severe COVID-19.

UK CBER Report Details Impact of COVID-19 on Kentucky’s Economy

Feb 3, 2021, 1:51 PM

According to the report, as of October, the state had recovered 67% of jobs lost during the first months of the pandemic. But the recovery remains far from complete. Kentucky’s employment was still down 107,600 jobs — or 5.5% — from January 2020.

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

Feb 1, 2021, 1:44 PM

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

Feb 1, 2021, 1:18 PM

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Why COVID-19 Vaccine Research Remains Critical

Jan 22, 2021, 8:58 AM

"While approved vaccines are able to prevent a COVID reinfection with a high effectiveness rate, it is still early on and we don't know how durable they are going to be in the long run. We also don’t know how effective these vaccines are at preventing asymptomatic spread. These questions are what researchers in my field will be looking at for many years to come."

COVID Vaccines: Fact Versus Fiction

Jan 14, 2021, 8:27 AM

Vince Venditto, PhD, assistant professor in the UK College of Pharmacy’s Department of Pharmaceutical Science, has extensive expertise in vaccine design. He was trained in organic synthesis and vaccine development. He is currently working on a clinical trial with community pharmacies to understand the prevalence of SARS-CoV-2 in Kentucky.

UK Study Provides Evidence for a 7-Day Quarantine for University Students Exposed to COVID-19

Dec 17, 2020, 8:26 AM

A new University of Kentucky study provides direct evidence for a testing strategy that could be used to support a shortened period of quarantine for university students who are exposed to the virus but are asymptomatic.

'Behind the Blue' - Part Three: The Vaccines to Combat a Coronavirus With Brooke Hudspeth and Vincent Venditto

Dec 9, 2020, 8:44 AM

In our third and final part of this interview, we ask Vince and Brooke about how this pandemic possibly ends, and how we progress into a new world after COVID-19.

Filter News

Unit

News type

Topic

Series